0 results for 'Winston Strawn'
Shoring Up a Faltering Shearman
After a tough few years, Shearman & Sterling has a new leader charged with keeping the 133-year-old patrician firm in the top tier.Cascades Ventures Inc.--a descendant of the "original patent troll"--may have reached the end of its campaign against the self-described troll-fighter RPX Corporation and a quintet of tech companies that allegedly orchestrated an illegal boycott of Cascades's patents.
Rather than spend eight weeks defending their client in front of a Salt Lake City jury, DLA Piper and Wilmer Cutler Pickering Hale and Dorr guided Pfizer Inc. to a $450 million settlement with Brigham Young University. The deal brings an end to a hard-fought case in which BYU initially sought billions, and Pfizer cycled through three sets of lawyers.
For more than 40 years, California was out of synch with the U.S. Supreme Court, permitting defendants in state antitrust actions to argue that direct purchasers suffered no harm because they passed price increases on to consumers. With a ruling Monday that eliminates the pass-through defense, California's now in step with the federal courts.
Going Solo? Get a Practice Management System
With a minimum of cost and effort, you can project an image of professionalism while having the confidence that your practice is being well managed. Say hello to practice management software -- your new best friend.Trademark Lawsuits: The Price of Online Griping
The Internet serves as a haven of outcry for disgruntled customers who create "gripe sites" aimed at their company of choice. The companies have cried foul, and are calling their antagonists to court for trademark infringement. Critics of the lawsuits, like Paul Levy of the Public Citizen Litigation Group, say they're being used to "suppress perfectly legitimate, noncommercial speech."In its infringement suit against three competitors, Fujitsu hoped to have some of the same magic in Judge Lucy Koh's courtroom that Apple enjoyed against Samsung. But after a two-week trial, jurors quickly rejected Fujitsu's claims.
The drug at issue, Yasmin, not only prevents pregnancy but also offers the desirable side effect of reducing bloating. But a federal district court ruled that Bayer's patented technique for increasing the absorption of a key ingredient was obvious, given the prior art.
"Tainted baby formula" has a terrifying ring to it, and it would seem tailor-made for a mass tort. But Abbott's lawyers at Patterson Belknap are doing their best to keep a tight lid on their client's liability.
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now